BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:JADE201 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of JADE201\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07533955-6530@assetmemo.bio
DTSTAMP:20261121T005332Z
DTSTART;VALUE=DATE:20271031
DTEND;VALUE=DATE:20271101
SUMMARY:JADE201: Phase 1 readout est. (NCT07533955)
DESCRIPTION:JADE201\, phase 1\, Rheumatoid Arthritis.\nStudy: A Phase 1 Stu
 dy of JADE201 in Participants With Rheumatoid Arthritis\nEstimated primary
  completion: October 2027. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/jade201#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT07533955
URL:https://assetmemo.bio/drug/jade201#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
